I mean there probably isn't much of a way out. It all comes down to funding. It is very rare for MedTech startups to have funding to actually establish themsel

I mean there probably isn't much of a way out. It all comes down to funding. It is very rare for MedTech startups to have funding to actually establish themselves in mature market, most of them will have funding to get pass regulator hurdles or just create an IP moat around the business, then the VC's expectation is that another giant will buy them out who will then have the purse to take products to market at scale. My worry is that more and more the bigger companies are buying or owning parts of startups sooner and sooner in the technology readiness pipeline. That will probably limit how much we actually innovate, both from the startup side that now has oversight and from the internal R&D ranks at big corp, that become glorified PMs and strategists rather than researchers. The only way forward is for VC's to stay for longer horizons, but specially in MedTech if you are selling something that involves a widget or hardware it will probably never scale in a way that would make it an interesting business for VC's. Perhaps the exception now is MedTech with SaaS type business models or cloud based services.